Search results
Review the results we have found for you.
Use the filters to narrow down the results list and easily find the trial you look for.
1 Trial StatusRecruiting1 A Phase 1 Study of KSQ-4279 Alone and in Combination in Patients With Advanced Solid Tumors
- Cancer,
- Solid Tumors,
- Advanced Solid Tumors
- NCT05240898, WP45169, KSQ-4279-1101
2 Trial StatusRecruiting2 A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-1971 in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors
- Cancer,
- Solid Tumors,
- Advanced Solid Tumors,
- Metastatic Solid Tumors
- NCT05487235, GO43712, 2021-006479-40
3 Trial StatusRecruiting3 A Dose-escalation Study of RO7567132 as Single Agent and in Combination With Atezolizumab in Participants With Advanced Solid Tumors
- Cancer,
- Solid Tumors,
- Advanced Solid Tumors,
- Metastatic Solid Tumors
- NCT06537310, BP44956, 2024-512839-70-00
4 Trial StatusRecruiting4 A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors
- Cancer,
- Head and Neck Cancer,
- Squamous Cell Carcinoma,
- Squamous Cell Carcinoma of the Head and Neck (SCCHN),
- Solid Tumors,
- Advanced Solid Tumors,
- Esophageal Cancer,
- Hepatocellular Carcinoma (HCC),
- Lung Cancer,
- Non-Small Cell Lung Cancer (NSCLC),
- Breast Cancer,
- Triple Negative Breast Cancer,
- Gastric Cancer,
- Metastatic Solid Tumors,
- Renal Cell Cancer (RCC),
- Clear Cell Renal Cell Carcinoma,
- Melanoma,
- Cervical Cancer,
- Bladder Cancer,
- Urothelial Carcinoma
- NCT05581004, GO43860, 2021-006708-34
5 Trial StatusRecruiting5 A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7566802 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors
- Cancer,
- Solid Tumors,
- Metastatic Solid Tumors,
- Advanced Solid Tumors
- NCT06031441, GO44431, 2023-509266-38-00
6 Trial StatusRecruiting6 A clinical trial to look at how safe and well RO7589831 works at different doses in people with advanced solid tumours, and how the body processes RO7589831
A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of RO7589831 as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
- Cancer,
- Solid Tumors,
- Advanced Solid Tumors
- NCT06004245, BP44474, 2023-503170-20-01
7 Trial StatusRecruiting7 A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-6036 in Patients With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation
- Cancer,
- Solid Tumors,
- Advanced Solid Tumors,
- Lung Cancer,
- Non-Small Cell Lung Cancer (NSCLC),
- Colorectal Cancer (CRC),
- Non Small Cell Lung Carcinoma
- NCT04449874, GO42144, 2020-000084-22, 2023-506311-18-00
8 Trial StatusCompleted8 Safety and Pharmacokinetics (PK) of Escalating Doses of MTIG7192A as a Single Agent and in Combination With Atezolizumab in Locally Advanced or Metastatic Tumors
- Cancer,
- Solid Tumors,
- Advanced Solid Tumors,
- Metastatic Solid Tumors
- NCT02794571, GO30103, 2016-000944-33
9 Trial StatusTerminated9 Oral Immunomodulatory Tyrosine Kinase Inhibitor in Patients With Locally Advanced or Metastatic Solid Tumors
- Cancer,
- Solid Tumors,
- Advanced Solid Tumors,
- Metastatic Solid Tumors
- NCT03454243, RXDX-106-01